Evaluation of non-invasive ventilation compliance in obstructive sleep apnea syndrome or obesity hypoventilation syndrome patients: an observational study
DOI:
https://doi.org/10.18203/2320-6012.ijrms20205025Keywords:
OSAS/OHS, NIV, ComplianceAbstract
Background: Recent times have seen the rise in obstructive sleep apnea syndrome/obesity hypoventilation syndrome (OSAS/OHS) patients across the globe. Availability of sleep study centers, questionnaires, and more awareness have made the diagnosis of OSAS/OHS early. But still, the majority of patients suffer from morbidity associated with OSAS/OHS despite the better diagnosis, the most common cause being non-adherence to (CPAP). This needs to be addressed more vigilantly and with utmost importance for successful management of OSAS/OHS.
Methods: This is an observational study, we selected patients by reviewing sleep study records at a tertiary care center (Rohilkhand medical college and hospital) in Bareilly, India. All diagnosed patients with OSAS/OHS (i.e. AHI >5) were telephoned and enquired about symptoms and non-invasive ventilation (NIV) use. They were evaluated using a self-designed questionnaire.
Results: In our study, we had total of 49 OSAS/OHS patients with mean age of 50.6 years and mean BMI of 35.63. Male patients were 37 (75.5%) and at the time of diagnosis AHI (mean) was 60.67 events/hour. In NIV users there were 24 patients (48.97%), 22 patients (91.7%) feel they have been benefitted from CPAP and 2 patients (8.3%) do not feel benefit from CPAP (NIV) use. Among NIV users there was significant drop of AHI (mean) to 8.07. Among NIV users there was a reduction in symptoms like excessive day time sleepiness in 18 patients (81.81%), witnessed apnea in 15 patients (88.23%), snoring in 21 patients (91.30%), blood pressure in 3 patients (21.42%), blood sugar levels in 2 patients (20%), morning headache in 5 patients (83.30%), depressive mood in 2 patients (40%), perceived memory loss in 3 patients (33.3%), sense of choking in 17 patients (94.4%) and weight loss in 19 patients (76%).
Conclusions: CPAP significantly improves symptoms and provides objective as well as subjective benefit to OSAS/OHS patients but still significant proportion of patients hesitate to initiate the therapy. Poor education/awareness regarding OSAS/OHS and non-availability of affordable CPAP remains the leading cause of non-compliance. There is a need for early education, reinforcement and affordable CPAP therapy.
References
Young T, Peppard PE, Gottlieb DJ. Epidemiology of obstructive sleep apnoea: a population health perspective. Am J Resp Critical Care Med. 2002;165(9):1217-39.
Senthilvel E, Auckley D, Dasarathy J. Evaluation of sleep disorders in the primary care setting: history taking compared to questionnaires. J Clinical Sleep Med. 2011;7(1):41-8.
Sawyer AM, King TS, Hanlon A, Richards KC, Sweer L, Rizzo A et al. Risk assessment for CPAP nonadherence in adults with newly diagnosed obstructive sleep apnoea: preliminary testing of the Index for Nonadherence to PAP (I-NAP). Sleep Breathing. 2014;18(4):875-83.
Bixler EO, Vgontzas AN, Ten Have T, Tyson K, Kales A. Effects of age on sleep apnoea in men: I. Prevalence and severity. Am J Resp Critical Care Med. 1998;157(1):144-8.
Durán J, Esnaola S, Rubio R, Iztueta Á. Obstructive sleep apnoea–hypopnea and related clinical features in a population-based sample of subjects aged 30 to 70 yr. Am J Resp Critical Care Med. 2001;163(3):685-9.
Bixler EO, Vgontzas AN, Lin HM, Ten Have T, Rein J, Vela-Bueno A et al. Prevalence of sleep-disordered breathing in women: effects of gender. Am J Resp Critical Care Med. 2001;163(3):608-13.
Stansbury RC, Strollo PJ. Clinical manifestations of sleep apnea. J thoracic dis. 2015;7(9):E298.
Nicolini A, Banfi P, Grecchi B, Lax A, Walterspacher S, Barlascini C et al. Non-invasive ventilation in the treatment of sleep-related breathing disorders: A review and update. Revista Portuguesa De Pneumologia. 2014;20(6):324-35.
Piper AJ, Wang D, Yee BJ, Barnes DJ, Grunstein RR. Randomised trial of CPAP vs bilevel support in the treatment of obesity hypoventilation syndrome without severe nocturnal desaturation. Thorax. 2008;63(5):395-401.
Howard ME, Piper AJ, Stevens B, Holland AE, Yee BJ, Dabscheck E, et al. A randomised controlled trial of CPAP versus non-invasive ventilation for initial treatment of obesity hypoventilation syndrome. Thorax. 2017;72(5):437-44.
Corral J, Mogollon MV, Sánchez-Quiroga MÁ, de Terreros JG, Romero A, Caballero C et al. Echocardiographic changes with non-invasive ventilation and CPAP in obesity hypoventilation syndrome. Thorax. 2018;73(4):361-8.
Hoffstein V, Viner S, Mateika S, Conway J. Treatment of obstructive sleep apnea with nasal continuous positive airway pressure. Am Rev Respir Dis. 1992;145(841):e5.
Meslier N, Lebrun T, Grillier-Lanoir V, Rolland N, Henderick C, Sailly JC et al. A French survey of 3,225 patients treated with CPAP for obstructive sleep apnoea: benefits, tolerance, compliance and quality of life. Eur Respiratory J. 1998;12(1):185-92.
Elkhouli O, Wolkove N, Baltzan M. Predictors of continuous positive airway pressure (CPAP) compliance and satisfaction after split-night protocol. Chest. 2005;128(4):222S.